Clicky

Cytokinetics, Incorporated(CYTK) News

Date Title
Oct 16 Is Cytokinetics Inc. (CYTK) the Most Promising Biotech Stock According to Hedge Funds?
Oct 16 Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day
Oct 2 Cytokinetics to Host Investor & Analyst Day on October 16, 2024
Oct 1 Is Cytokinetics Inc. (CYTK) Positioned for Success with Its Innovative Muscle Modulators?
Sep 30 Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
Sep 27 Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
Jul 30 Investors in Cytokinetics (NASDAQ:CYTK) have seen incredible returns of 381% over the past five years
Jul 30 Cytokinetics Announces Call for Proposals for Corporate Giving Program
Jul 25 Cytokinetics to Announce Second Quarter Results on August 8, 2024
Jul 25 Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?
Jul 23 Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
Jun 12 Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development
Jun 10 Insider Sale: Director Muna Bhanji Sells Shares of Cytokinetics Inc (CYTK)
Jun 5 Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
Jun 5 Insider Sale: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
May 29 Cytokinetics to Participate in June Investor Conferences
May 28 Cytokinetics Announces Closing of Public Offering of Common Stock
May 27 Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now?
May 24 Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
May 23 Cytokinetics secures up to $575M in royalty deal, frustrating investors